These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2627107)

  • 1. [Alpress osmotic tablets: a major advance in the management of hypertensive patients].
    Alvart R
    Ann Cardiol Angeiol (Paris); 1989 Dec; 38(9 Pt 2):599-601. PubMed ID: 2627107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy, tolerance and incidence of risk factors of Alpress in the treatment of arterial hypertension].
    Neimann JL
    Ann Cardiol Angeiol (Paris); 1989 Dec; 38(9 Pt 2):587-90. PubMed ID: 2627105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alpha-1 inhibition. Clinical studies of the efficacy and tolerability of Alpress LP in mild to moderate essential hypertension].
    Luccioni R; Chestier Y; Galinier M; Charbonnier B
    Ann Cardiol Angeiol (Paris); 1990 Dec; 39(10 ( Pt 2)):631-6. PubMed ID: 2100975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alpha-1 inhibition and blood pressure regulation].
    Drici MD
    Ann Cardiol Angeiol (Paris); 1990 Dec; 39(10 ( Pt 2)):629-30. PubMed ID: 1983165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of and tolerance to prolonged release prazosin in patients with hypertension and non-insulin dependent diabetes].
    Hanon O; Giacomino A; Troy S; Bernaud C; Girerd X; Weber S
    Ann Cardiol Angeiol (Paris); 2000 Oct; 49(7):390-6. PubMed ID: 12555491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Weak transplacental passage of prazosin (Alpress) during the third trimester of pregnancy. 3 cases].
    Bourget P; Fernandez H; Ribou F; Edouard D; Frydman R
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(8):871-4. PubMed ID: 8132964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardura XL--a unique drug formulation--doxazosine administered in a slow-release form (doxazosine GITS)].
    Grzeszczak W
    Przegl Lek; 2000; 57(11):643-54. PubMed ID: 11293213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on controlled release effervescent osmotic pump tablets from Traditional Chinese Medicine Compound Recipe.
    Li XD; Pan WS; Nie SF; Wu LJ
    J Control Release; 2004 May; 96(3):359-67. PubMed ID: 15120893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of monolithic osmotic pump system by coating the indented core tablet.
    Liu L; Che B
    Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs).
    Okimoto K; Tokunaga Y; Ibuki R; Irie T; Uekama K; Rajewski RA; Stella VJ
    Int J Pharm; 2004 Nov; 286(1-2):81-8. PubMed ID: 15501004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ; Jaguste V; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and evaluation of osmotic pump tablets of naproxen sodium.
    Ramakrishna N; Mishra B
    Pharmazie; 2001 Dec; 56(12):958-62. PubMed ID: 11802660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The quality of life of hypertensive patients treated with prazosin (sustained-release) or enalapril: a randomized controlled trial over 24 weeks].
    Consoli SM; Troy S; Bernaud C
    Therapie; 2000; 55(2):259-67. PubMed ID: 10967698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sandwiched osmotic tablet core for nifedipine controlled delivery.
    Liu L; Khang G; Rhee JM; Lee HB
    Biomed Mater Eng; 1999; 9(5-6):297-310. PubMed ID: 10822485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of a new rate-controlled formulation of prazosin in the treatment of hypertension during pregnancy: transplacental passage of prazosin.
    Bourget P; Fernandez H; Edouard D; Lesne-Hulin A; Ribou F; Baton-Saint-Mleux C; Lelaidier C
    Eur J Drug Metab Pharmacokinet; 1995; 20(3):233-41. PubMed ID: 8751046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of prazosin administered as gastro-intestinal-therapeutic-systems to 24 healthy volunteers.
    Fourtillan JB; Brisson AM; Couet W
    Therapie; 1993; 48(2):115-8. PubMed ID: 8351678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.